Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

cyclopia sequence 8Lung Neoplasms 3Pain 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Sleepiness 1Peripheral Nervous System Diseases 1Parasomnias 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Hypesthesia 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Fatigue 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Anxiety Disorders 1Anorexia 1Acute Pain 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Minocycline × Clear all
NCT01693523 2020-03-09

Minocycline Study in Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled 10 charts
Gastrointestinal

cyclopia sequence, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡